A Calcium Channel Blocker for ME/CFS and Fibromyalgia? Nimodipine Pt. II
Remy reviews how Nimodipine or Nimotop may be able to help with the pain, mitochondrial problems, immune system issues and cognitive problems in fibromyalgia and ME/CFS. She examines protocol, doses and cost as relates her experience with the drug.
Inflammation and Energy Issues Highlighted in Fibromyalgia
A Molecular Revolution We are in the midst of a molecular revolution. Instead of plucking out individual factors and studying them, researchers are ploughing through immense amounts of data to try and get at the molecular roots of illness. They’re using genetic,...
Death in Chronic Fatigue Syndrome (ME/CFS) – What has it Told Us? The Autopsy Files
It’s always hard to lose a loved one, but the deaths in ME/CFS seem particularly hard. They tend to be quite painful, they often take place in the midst of a non-supportive medical system, and they’re a complete mystery. With no seeming way out it’s...
Taking a Stand: Fibromyalgia, Orthostatic Intolerance and the Autonomic Nervous System
Numerous tilt table studies indicate that orthostatic intolerance (increased symptoms while standing) is common in fibromyalgia - placing it in a similar disease category as chronic fatigue syndrome and postural orthostatic intolerance syndrome (POTS). Sleep issues, pain, fatigue, allodynia, anxiety, irritable bowel and others could all result from the autonomic nervous system problems found in these diseases.
HEAL II: The NIH’s Big Opioid and Pain Initiative Gets More Teeth
The HEAL Initiative (Helping End Addiction Long Term) is one of the rare NIH initiatives that presents real possibilities for a long neglected population. It took an act of Congress – which gave the NIH $500 million and specifically directed them to use it attack...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
